vs

Side-by-side financial comparison of USA Compression Partners, LP (USAC) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.

USA Compression Partners, LP is the larger business by last-quarter revenue ($252.5M vs $209.6M, roughly 1.2× Varex Imaging Corp). USA Compression Partners, LP runs the higher net margin — 11.0% vs 1.1%, a 9.9% gap on every dollar of revenue. On growth, Varex Imaging Corp posted the faster year-over-year revenue change (4.9% vs 2.7%). USA Compression Partners, LP produced more free cash flow last quarter ($87.7M vs $-26.8M). Over the past eight quarters, USA Compression Partners, LP's revenue compounded faster (4.9% CAGR vs 0.8%).

USA Compression Partners, LP is a US-based provider of natural gas compression services and related infrastructure solutions. It serves clients across the upstream, midstream, and downstream segments of the oil and gas industry, offering custom compression systems, maintenance, and operational support to facilitate efficient natural gas production, processing, and transportation.

Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.

USAC vs VREX — Head-to-Head

Bigger by revenue
USAC
USAC
1.2× larger
USAC
$252.5M
$209.6M
VREX
Growing faster (revenue YoY)
VREX
VREX
+2.2% gap
VREX
4.9%
2.7%
USAC
Higher net margin
USAC
USAC
9.9% more per $
USAC
11.0%
1.1%
VREX
More free cash flow
USAC
USAC
$114.5M more FCF
USAC
$87.7M
$-26.8M
VREX
Faster 2-yr revenue CAGR
USAC
USAC
Annualised
USAC
4.9%
0.8%
VREX

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
USAC
USAC
VREX
VREX
Revenue
$252.5M
$209.6M
Net Profit
$27.8M
$2.3M
Gross Margin
33.3%
Operating Margin
30.3%
7.3%
Net Margin
11.0%
1.1%
Revenue YoY
2.7%
4.9%
Net Profit YoY
9.1%
866.7%
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
USAC
USAC
VREX
VREX
Q1 26
$209.6M
Q4 25
$252.5M
$228.9M
Q3 25
$250.3M
$203.0M
Q2 25
$250.1M
$212.9M
Q1 25
$245.2M
$199.8M
Q4 24
$245.9M
Q3 24
$240.0M
$205.7M
Q2 24
$235.3M
$209.1M
Net Profit
USAC
USAC
VREX
VREX
Q1 26
$2.3M
Q4 25
$27.8M
$12.2M
Q3 25
$34.5M
$-89.1M
Q2 25
$28.6M
$6.9M
Q1 25
$20.5M
$-300.0K
Q4 24
$25.4M
Q3 24
$19.3M
$-51.1M
Q2 24
$31.2M
$1.4M
Gross Margin
USAC
USAC
VREX
VREX
Q1 26
33.3%
Q4 25
34.0%
Q3 25
33.3%
Q2 25
36.0%
Q1 25
34.3%
Q4 24
Q3 24
32.6%
Q2 24
32.0%
Operating Margin
USAC
USAC
VREX
VREX
Q1 26
7.3%
Q4 25
30.3%
8.6%
Q3 25
33.5%
-39.8%
Q2 25
30.6%
10.4%
Q1 25
28.3%
5.6%
Q4 24
30.3%
Q3 24
31.5%
5.3%
Q2 24
32.9%
4.4%
Net Margin
USAC
USAC
VREX
VREX
Q1 26
1.1%
Q4 25
11.0%
5.3%
Q3 25
13.8%
-43.9%
Q2 25
11.4%
3.2%
Q1 25
8.4%
-0.2%
Q4 24
10.3%
Q3 24
8.1%
-24.8%
Q2 24
13.3%
0.7%
EPS (diluted)
USAC
USAC
VREX
VREX
Q1 26
$0.05
Q4 25
$0.29
Q3 25
$-2.15
Q2 25
$0.17
Q1 25
$-0.01
Q4 24
Q3 24
$-1.25
Q2 24
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
USAC
USAC
VREX
VREX
Cash + ST InvestmentsLiquidity on hand
$8.6M
$125.6M
Total DebtLower is stronger
$2.5B
$367.6M
Stockholders' EquityBook value
$476.9M
Total Assets
$2.6B
$1.1B
Debt / EquityLower = less leverage
0.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
USAC
USAC
VREX
VREX
Q1 26
$125.6M
Q4 25
$8.6M
$155.1M
Q3 25
$152.6M
Q2 25
$2.0K
$223.0M
Q1 25
$2.0K
$212.6M
Q4 24
$14.0K
Q3 24
$79.0K
$200.5M
Q2 24
$9.0K
$190.0M
Total Debt
USAC
USAC
VREX
VREX
Q1 26
$367.6M
Q4 25
$2.5B
$367.5M
Q3 25
$2.5B
$367.5M
Q2 25
$2.5B
$567.2M
Q1 25
$2.5B
$567.0M
Q4 24
$2.5B
Q3 24
$2.5B
$443.4M
Q2 24
$2.5B
$443.1M
Stockholders' Equity
USAC
USAC
VREX
VREX
Q1 26
$476.9M
Q4 25
$472.6M
Q3 25
$455.3M
Q2 25
$549.7M
Q1 25
$540.2M
Q4 24
Q3 24
$529.1M
Q2 24
$581.2M
Total Assets
USAC
USAC
VREX
VREX
Q1 26
$1.1B
Q4 25
$2.6B
$1.1B
Q3 25
$2.7B
$1.1B
Q2 25
$2.7B
$1.4B
Q1 25
$2.7B
$1.3B
Q4 24
$2.7B
Q3 24
$2.8B
$1.2B
Q2 24
$2.8B
$1.3B
Debt / Equity
USAC
USAC
VREX
VREX
Q1 26
0.77×
Q4 25
0.78×
Q3 25
0.81×
Q2 25
1.03×
Q1 25
1.05×
Q4 24
Q3 24
0.84×
Q2 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
USAC
USAC
VREX
VREX
Operating Cash FlowLast quarter
$139.5M
$-16.1M
Free Cash FlowOCF − Capex
$87.7M
$-26.8M
FCF MarginFCF / Revenue
34.8%
-12.8%
Capex IntensityCapex / Revenue
20.5%
5.1%
Cash ConversionOCF / Net Profit
5.02×
-7.00×
TTM Free Cash FlowTrailing 4 quarters
$277.0M
$-13.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
USAC
USAC
VREX
VREX
Q1 26
$-16.1M
Q4 25
$139.5M
$7.9M
Q3 25
$75.9M
$7.7M
Q2 25
$124.2M
$16.6M
Q1 25
$54.7M
$9.5M
Q4 24
$130.2M
Q3 24
$48.5M
$25.9M
Q2 24
$96.7M
$8.0M
Free Cash Flow
USAC
USAC
VREX
VREX
Q1 26
$-26.8M
Q4 25
$87.7M
$2.3M
Q3 25
$51.9M
$1.4M
Q2 25
$101.1M
$9.8M
Q1 25
$36.3M
$5.3M
Q4 24
$101.2M
Q3 24
$19.8M
$19.9M
Q2 24
$48.2M
$3.3M
FCF Margin
USAC
USAC
VREX
VREX
Q1 26
-12.8%
Q4 25
34.8%
1.0%
Q3 25
20.7%
0.7%
Q2 25
40.4%
4.6%
Q1 25
14.8%
2.7%
Q4 24
41.1%
Q3 24
8.2%
9.7%
Q2 24
20.5%
1.6%
Capex Intensity
USAC
USAC
VREX
VREX
Q1 26
5.1%
Q4 25
20.5%
2.4%
Q3 25
9.6%
3.1%
Q2 25
9.3%
3.2%
Q1 25
7.5%
2.1%
Q4 24
11.8%
Q3 24
12.0%
2.9%
Q2 24
20.6%
2.2%
Cash Conversion
USAC
USAC
VREX
VREX
Q1 26
-7.00×
Q4 25
5.02×
0.65×
Q3 25
2.20×
Q2 25
4.35×
2.41×
Q1 25
2.66×
Q4 24
5.12×
Q3 24
2.51×
Q2 24
3.10×
5.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

USAC
USAC

Revenue From Contract Operations Excluding Revenue From Related Party$231.7M92%
Entities Affiliated With Energy Transfer LP$16.6M7%
Transferred At Point In Time$5.4M2%

VREX
VREX

Medical Segment$144.8M69%
Industrial Segment$64.8M31%

Related Comparisons